Company Search:
Advanced Search
Sponsored Links
Repro-Med Systems, Inc. Company Snapshot
Repro-Med Systems, Inc. operates within the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Repro-Med Systems with three other companies in this sector in the United States: Sonoma Pharmaceuticals Inc (2017 sales of $12.83 million of which 100% was Drugs & Devices), Encision Inc. ($8.87 million ), and Isoray, Inc. ($4.76 million of which 100% was Medical Devices).

Sales Analysis. During the year ended February of 2017, sales at Repro-Med Systems were $12.29 million. This is a very small increase of 0.4% versus 2016, when the company's sales were $12.25 million. This was the fifth consecutive year of sales increases at Repro-Med Systems (and since 2012, sales have increased a total of 92%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Repro-Med Systems, Inc.
  Stock Performance Chart for Repro-Med Systems, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 1.00
(Figures in U.S. Dollars)
1 Week -1.0%   13 Weeks 8.7%  
4 Weeks 96.1%   52 Weeks 129.9%  
Repro-Med Systems, Inc. Key Data:
  Ticker: REPR Country: United States
  Exchanges: OTC Major Industry: Health Care Equipment & Services
    Sub Industry: Surgical & Medical Instruments
  2017 Sales 12,293,655
(Year Ending Jan 2018).
Employees: 63
  Currency: U.S. Dollars Market Cap: 37,834,871
  Fiscal Yr Ends: February Shares Outstanding: 37,834,871
  Share Type: Common Closely Held Shares: 16,896,312
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.